MDS: what's the impact of early diagnosis?
1 Views
administrator
07/04/23
David Steensma, MD, Dana-Farber Cancer Institute, Boston, MA, discusses myelodysplastic syndromes (MDS) diagnostic patterns, early versus later diagnosis and the impact on patient outcomes. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.
-
Category
Show more
Facebook Comments
No comments found